N Engl J Med. 2002 Sep 5;347(10):756-8.

HIV-1 superinfection--a word of caution.

Goulder PJ, Walker BD.

Comment on

A patient with HIV-1 superinfection. [N Engl J Med. 2002]
A patient with HIV-1 superinfection.Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, Autran B, Goh LE, Perrin L. N Engl J Med. 2002 Sep 5; 347(10):731-6.

PMID:: 12213949; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

AIDS Vaccines

LinkOut - more resources

Full Text Sources

Medical

HIV/AIDS - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review HIV-1 superinfection and its implications for vaccine design. [Curr HIV Res. 2010]
Review HIV-1 superinfection and its implications for vaccine design.
Chohan BH, Piantadosi A, Overbaugh J. Curr HIV Res. 2010 Dec; 8(8):596-601.
Review Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development. [AIDS. 2000]
Review Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
Heeney JL, Hahn BH. AIDS. 2000; 14 Suppl 3:S125-7.
Antibody neutralization. [Curr HIV Res. 2007]
Antibody neutralization.
Cole KS, Ross TM. Curr HIV Res. 2007 Nov; 5(6):505-6.
Tiny steps towards an HIV vaccine. [Nature. 2010]
Tiny steps towards an HIV vaccine.
Willyard C. Nature. 2010 Jul 15; 466(7304):S8.
Review Vaccines and immunology. Recent advances in HIV/AIDS vaccine development. [AIDS. 2001]
Review Vaccines and immunology. Recent advances in HIV/AIDS vaccine development.
Landay A, Heeney JL. AIDS. 2001; 15 Suppl 5:S101-3.

See reviews... See all...

Cited by 6 PubMed Central articles

Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery. [J Am Chem Soc. 2007]
Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery.
Tam VK, Kwong D, Tor Y. J Am Chem Soc. 2007 Mar 21; 129(11):3257-66. Epub 2007 Feb 24.
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial. [AIDS Res Hum Retroviruses. 2006]
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.
Jobes DV, Daoust M, Nguyen VT, Padua A, Sinangil F, Pérez-Losada M, Crandall KA, Oliphant T, Posada D, Rambaut A, et al. AIDS Res Hum Retroviruses. 2006 Oct; 22(10):968-78.
Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. [Vaccine. 2007]
Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.
Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC. Vaccine. 2007 Jan 15; 25(5):834-45. Epub 2006 Sep 22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

HIV-1 superinfection--a word of caution.
HIV-1 superinfection--a word of caution.
N Engl J Med. 2002 Sep 5 ;347(10):756-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

HIV-1 superinfection--a word of caution.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information